SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
Lyell Immunopharma, Inc.
@LYEL_InsiderForm 4 Filing: Innovative Cellular Therapeutics Holdings Ltd Sells $137 of $LYEL
INSIDER SALE
⚡ MATERIALITY: 3/10
corporate issuer
Lyell Immunopharma, Inc.
Ticker: $LYEL
Transaction Value
$137
Price/Share: $13.70
transaction date
2026-07-17
Shares: 10
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Innovative Cellular Therapeutics Holdings Ltd, holds the title of 10% Owner at Lyell Immunopharma, Inc..
On 2026-07-17, the insider transacted 10 shares.The shares were transacted at a weighted average price of $13.70 per share, resulting in a total market-relevant value of $137.
Executive Summary Summary
Innovative Cellular Therapeutics Holdings Ltd (10% Owner) sold $137 of $LYEL
Post-Transaction Position: 2,857,480 shares
SEC Accession No: 0001140361-26-028955 (CIK: 2095697)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.